ACETAMINOPHEN; HYDROCODONE BITARTRATE | A207709 | AUROLIFE PHARMA LLC
Highest NADAC/Unit
$0.2347
per ea
Lowest NADAC/Unit
$0.1623
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 13107021301HYDROCODONE-ACETAMINOPHEN 10-300 MG TABLET | $0.2347 | EA | Generic | — | 2026-06-17 |
| 13107021305HYDROCODONE-ACETAMINOPHEN 10-300 MG TABLET | $0.2347 | EA | Generic | — | 2026-06-17 |
| 13107021201HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET | $0.1905 | EA | Generic | — | 2026-06-17 |
| 13107021205HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET | $0.1905 | EA | Generic | — | 2026-06-17 |
| 13107021101HYDROCODONE-ACETAMINOPHEN 5-300 MG TABLET | $0.1623 | EA | Generic | — | 2026-06-17 |
| 13107021105HYDROCODONE-ACETAMINOPHEN 5-300 MG TABLET | $0.1623 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.